Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
4.
Int J Tuberc Lung Dis ; 22(2): 230-235, 2018 02 01.
Article in English | MEDLINE | ID: mdl-29506621

ABSTRACT

OBJECTIVE: To identify the risk factors for early and late relapse of haemoptysis after bronchial artery embolisation (BAE). DESIGN: We performed a retrospective study of 255 patients with haemoptysis who underwent BAE from January 2009 to June 2016 at the First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Using a Cox regression model, risk factors contributing to early (within the first month) and late (>1 month) recurrence were analysed. We censored recurrence-free patients at 1 month and patients without rebleeding after 1 month. RESULTS: The cumulative recurrence rate at 1, 6, 12, 24 and 48 months was respectively 14.9%, 16.9%, 20.6%, 31.0% and 39.9%, with a median follow-up of 574 days. Early relapse occurred in 38 of 255 patients, while late recurrence was found in 45 of the remaining 217 patients. The risk factors related to early recurrence were lung destruction on computed tomography of the chest and involvement of non-bronchial systemic arteries. The risk factors associated with late recurrence were tuberculosis sequelae, the presence of shunts and the use of gelfoam as an embolisation material. CONCLUSIONS: The variables related to incomplete embolisation were the risk factors for early rebleeding. The variables associated with same-vessel recanalisation and formation of a new collateral circulation influenced late recurrence.


Subject(s)
Bronchial Arteries , Hemoptysis/therapy , Embolization, Therapeutic/adverse effects , Female , Hemoptysis/etiology , Humans , Male , Middle Aged , Postoperative Complications , Recurrence , Regression Analysis , Retrospective Studies , Risk Factors , Time Factors , Treatment Outcome
5.
Zhonghua Jie He He Hu Xi Za Zhi ; 41(3): 196-200, 2018 Mar 12.
Article in Chinese | MEDLINE | ID: mdl-29518848

ABSTRACT

Objective: To investigate the clinical manifestations and prognostic factors of hospital death in connective tissue disease patients with acute respiratory failure caused by pneumocystis pneumonia (PCP) admitted to two medical intensive care units(MICU). Methods: A retrospective review was conducted for all connective tissue disease (CTD) patients with acute respiratory failure from PCP in MICU of 2 academic medical centers between 2010 and 2015. The patients were divided into survivors and non-survivors. Demographic and clinical data, including laboratory, radiological and microbiological findings, as well as therapy, clinical course, mortality and prognostic factors of hospital mortality were included in the analysis. Logistic regression models were used to determine the effect of prognostic factors on hospital death after adjusting for covariates of which the p values were less than 0.1. Results: A total of 41 patients with connective tissue disease were identified. The PaO(2)/FiO(2) ratio (PFR) on ICU admission was 120 mmHg(55-180 mmHg, 1 mmHg=0.133 kPa). Common clinical features included dyspnea (90.2%, 37/41), fever (87.8%, 36/41) and dry cough(65.9%, 30/41). 58.5%(24/41) and 17.1%(7/41) patients were co-infected by CMV and aspergillus, respectively. The overall mortality rate was 75.6%(31/41). Compared with survivors, the age, APACHEⅡ score and incidence of barotrauma in non-survivors were higher (39±17 vs 58±15, t=3.018, P=0.002), (15±6 vs 19±5, t=2.528, P=0.019), (0/10 vs 12/31, χ(2)=5.473, P=0.021), while PFR on ICU admission was lower in non-survivors (172±68 vs 116±49, t=-1.893, P=0.007). Logistic analysis showed that PFR on ICU admission was the independent risk factor for hospital death (OR=1.004, 95%CI: 1.002-1.006, P=0.048). Conclusions: Mortality rate among patients with acute respiratory failure secondary to CTD related PCP is still high, and the poor prognostic factors of hospital mortality included PFR on ICU admission and barotrauma.


Subject(s)
Connective Tissue Diseases/mortality , Hospital Mortality , Pneumonia, Pneumocystis/complications , Respiratory Insufficiency/etiology , Connective Tissue Diseases/diagnosis , Humans , Intensive Care Units , Pneumonia, Pneumocystis/microbiology , Prognosis , Respiratory Distress Syndrome , Retrospective Studies
6.
Zhonghua Yi Xue Za Zhi ; 96(38): 3057-3061, 2016 Oct 18.
Article in Chinese | MEDLINE | ID: mdl-27784445

ABSTRACT

Objective: To examine the clinical features of patients with acute respiratory failure (ARF) caused by pneumocystis pneumonia (PCP) admitted into two medical intensive care units (ICU) in non- human immunodeficiency virus (HIV) infected immunocompromised patients. Methods: A retrospective review was conducted among 92 non-HIV patients with ARF caused by PCP in medical ICU of Peking Union Medical College Hospital and China-Japan Friendship Hospital between Jan 2010 and Dec 2015. Patient characteristics, clinical presentation, laboratory and radiological findings, complications, as well as therapy and mortality were included in the analysis. Results: All patients were immunocompromised before PCP, among which 69.6% (64/92) patients were suffered from autoimmune disease. The diagnosis of PCP was made by the identification of P. jiroveci organisms with Giemsa or polymerase chain reaction in specimens of bronchoalveolar lavage, sputum or tracheal aspiration. The Acute Physiology and Chronic Health Evaluation (APACHE) Ⅱ was high (19±5) and the partial pressure of oxygen/ fraction of inspiration oxygen(PaO2/FiO2) ratio was low[(139.6±65.4) mmHg]on ICU admission, with all patients diagnosed as acute respiratory failure during ICU stay. Radiologic findings showed bilateral diffused ground glass opacity (94.6%, 87/92). All patients received Compound Sulfamethoxazole (SMZ/TMP) and only 3.3% (3/92) patients were not given conjunctive corticosteroid. 57.6% (53/92) and 21.7% (20/92) patients were coinfected by cytomegalovirus (CMV) and aspergillos. Invasive ventilatory support was required in 90% (81/90) patients. 22% (18/82) patients used non-invasive positive pressure ventilation (NPPV) on ICU admission but most of them (83.3%, 15/18) failed and switched to invasive positive pressure ventilation (IPPV). Median ICU and hospital length of stay were 11 and 17 days, respectively. The overall hospital mortality rate was 76.1% (70/92). Conclusions: Among patients with ARF secondary to non-HIV related PCP, autoimmune system diseases are the most common primary diagnosis. The clinical manifestations were severe and coinfections are common, with poor prognosis.


Subject(s)
Pneumocystis , Respiratory Distress Syndrome , APACHE , Adrenal Cortex Hormones , HIV Infections , Hospital Mortality , Humans , Immunocompromised Host , Intensive Care Units , Retrospective Studies
7.
Int J Tuberc Lung Dis ; 20(2): 276-81, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26792485

ABSTRACT

SETTING: Tertiary referral centre. OBJECTIVE: To retrospectively observe the characteristics of bronchial angiograms in the setting of systemic artery-pulmonary circulation shunts (SPS), and to evaluate the safety and effectiveness of bronchial artery embolisation (BAE) for these patients with life-threatening haemoptysis. DESIGN: The records of life-threatening haemoptysis patients with SPS who presented to a tertiary referral centre from January 2009 to March 2014 were reviewed. RESULTS: SPS consisted of bronchial artery-pulmonary artery shunt (AAS) in 30 cases, bronchial artery-pulmonary vein shunt (AVS) in 4 cases, non-bronchial systemic artery-pulmonary circulation shunt (n-BPS) in 7 cases and more than one type of SPS in 4 cases (AAS and AVS in 3 cases, three types of SPS in 1 case). BAE using polyvinyl alcohol (PVA) was successful in 97.8% (44/45) of the patients. Cumulative rates of freedom from recurrence at 1 month, 1 year and 2 years were respectively 97.8%, 93.2% and 85.4%. No major procedure-related complications occurred. No significant differences were found in recurrence rates or cumulative haemoptysis control rates among patients with different types of SPS complications (P = 0.55 and 0.46, respectively). CONCLUSION: BAE with PVA was safe and effective for life-threatening haemoptysis complicated by SPS.


Subject(s)
Bronchial Arteries/physiopathology , Embolization, Therapeutic/methods , Hemoptysis/therapy , Lung Diseases/complications , Polyvinyl Alcohol/administration & dosage , Pulmonary Artery/physiopathology , Pulmonary Veins/physiopathology , Adult , Aged , Bronchial Arteries/diagnostic imaging , Disease-Free Survival , Embolization, Therapeutic/adverse effects , Female , Hemoptysis/diagnosis , Hemoptysis/etiology , Hemoptysis/physiopathology , Humans , Lung Diseases/diagnosis , Lung Diseases/physiopathology , Male , Middle Aged , Polyvinyl Alcohol/adverse effects , Pulmonary Artery/diagnostic imaging , Pulmonary Circulation , Pulmonary Veins/diagnostic imaging , Recurrence , Referral and Consultation , Retrospective Studies , Tertiary Care Centers , Time Factors , Treatment Outcome
8.
Int J Impot Res ; 24(5): 191-5, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22592761

ABSTRACT

To prospectively compare the clinical responses and penile color-duplex ultrasound (PCDU) results of oral PDE5 inhibitors (PDE5-Is) with papaverine intracavernosal injection (ICI) and to evaluate whether PDE5-Is could be used as alternatives to vasoactive agent injections, 25 ED patients underwent PCDU three times with an interval of at least 1 week, using different pharmacological induction: ICI mode (30-60 mg papaverine), sildenafil mode (100 mg sildenafil) and tadalafil mode (20 mg tadalafil). The preference of the patients was collected when all tests were completed. No significant differences were found in peak systolic velocity and acceleration time among all three modes. However for the ICI mode, end diastolic velocity of the right cavernosal artery was significantly higher than those of the sildenafil and tadalafil modes 5 min after erection induction, and at 15 min it became lower than those of two PDE5-I modes. Consequently, resistance index of the right cavernosal artery in ICI mode was reversed at 5 and 15 min. In all, 60.0 and 56.0% patients managed to reach full erection in PDE5-Is modes, which was significantly lower than in ICI mode (80.0%). Therefore, although PDE5-Is and papaverine ICI showed similar effects on PCDU parameters in detecting arterial ED, more patients had better clinical responses to ICI, and oral PDE5-Is administration still showed some pitfalls in practical use.


Subject(s)
Impotence, Vasculogenic/drug therapy , Penile Erection/drug effects , Penis/blood supply , Penis/diagnostic imaging , Phosphodiesterase 5 Inhibitors/administration & dosage , Ultrasonography, Doppler, Color , Administration, Oral , Adult , Arteries/diagnostic imaging , Carbolines/administration & dosage , Humans , Injections , Male , Middle Aged , Papaverine/administration & dosage , Penis/drug effects , Piperazines/administration & dosage , Prospective Studies , Purines/administration & dosage , Sildenafil Citrate , Sulfones/administration & dosage , Tadalafil , Vasodilator Agents/administration & dosage
9.
J Nanosci Nanotechnol ; 9(2): 1025-8, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19441446

ABSTRACT

Dimercaptosuccinic acid-coated maghemite nanoparticles and their protamine derivatives were prepared. TEM revealed that the average size of nanoparticles is 10 nm and derivatives with larger size consist of several original nanoparticles. The cellular uptake of nanoparticles and derivatives by human hepatoma cells, and their effects on cell viability and cell-cycle were detected. Results showed that the internalization of nanoparticles into cells was very limited, while derivatives could be internalized into cells with high efficiency. Nanoparticles didn't display significant cytotoxicity at a wide range of concentrations (0.3-2.4 mg/ml), whereas derivatives had a narrow range of non-toxicity concentrations (0.3-0.6 mg/ml). Both nanoparticles and derivatives could affect cell-cycle progress and the mechanisms underlying were discussed.


Subject(s)
Cell Cycle/drug effects , Ferric Compounds/chemistry , Nanoparticles , Protamines/chemistry , Ferric Compounds/pharmacology , Microscopy, Electron, Transmission
SELECTION OF CITATIONS
SEARCH DETAIL
...